Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Increased risk of anemia, neutropenia and thrombocytopenia in people with HIV and well-controlled viral replication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Blodsygdomme

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiUndervisningpeer review

  3. Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Francesco d'Amore
  • Thomas Relander
  • Grete F Lauritzsen
  • Esa Jantunen
  • Hans Hagberg
  • Harald Anderson
  • Harald Holte
  • Anders Österborg
  • Mats Merup
  • Peter Brown
  • Outi Kuittinen
  • Martin Erlanson
  • Bjørn Østenstad
  • Unn-Merete Fagerli
  • Ole Vestergaard Gadeberg
  • Christer Sundström
  • Jan Delabie
  • Elisabeth Ralfkiaer
  • Martine Vornanen
  • Helle Toldbod
Vis graf over relationer
Systemic peripheral T-cell lymphomas (PTCLs) respond poorly to conventional therapy. To evaluate the efficacy of a dose-dense approach consolidated by up-front high-dose chemotherapy (HDT) and autologous stem-cell transplantation (ASCT) in PTCL, the Nordic Lymphoma Group (NLG) conducted a large prospective phase II study in untreated systemic PTCL. This is the final report, with a 5-year median follow-up, of the NLG-T-01 study.
TidsskriftJournal of Clinical Oncology
Udgave nummer25
Sider (fra-til)3093-9
Antal sider7
StatusUdgivet - 2012

ID: 36554097